Hilary Kramer

Hilary Kramer

Hilary Kramer is one of Wall Street’s most successful equity analysts and investment managers, with a reputation as a leading expert on today’s market movements, stock trends and economic outlook.

She received her MBA from the Wharton School at the University of Pennsylvania and her BA from Wellesley College with honors. Hilary Kramer got her start on Wall Street more than two decades ago at Lehman Brothers and Morgan Stanley where she was an analyst in the investment banking group covering natural resources, diversified industrials and energy companies. She was also the chief investment officer of a family office — overseeing a $5.2 billion global private equity and publicly-traded equity fund, and co-vice chairman of the $500 million Ibero-American Partners Fund (1997 to 2003).

In 2004, Hilary’s A&G Capital formed a specialized research arm and investment fund. The GreenTech 21st Century Master Fund focused on companies engaged in alternative energy, clean technologies, environmental infrastructure and services, agricultural and natural resources.

Today, Hilary Kramer is an in-demand commentator whose work often appears in investing publications such as the Wall Street Journal, New York Post, Bloomberg, Business Insider and Reuters and is a regular on CNBC, CNN and the Fox News Channel, providing stock market insight and economic observations.

Hilary Kramer is also the editor of several financial advisory services designed to help individual investors profit from her stock picking talents: Value Authority, GameChangers, Breakout Stocks, High Octane Trader, Absolute Capital Return, Inner Circle and Inner Circle Pro.

Recent Articles

Trade of the Day: Cytokinetics (CYTK)

Though this pharmaceutical stock has been battered lately, both analysts and management are confident in the company's drug currently in the FDA pipeline.

Flash Freeze Won’t Slow The Nasdaq Down

Last week's NDAQ trading glitch may have cost it some reputation points, but savvy investors know it was truly a glitch and the stock will is a good play

5 Stocks for the Post-PC Age

Technology is constantly changing, and while PCs were all the rage they are going out while tablets are on their way in. Look to these five stocks for growth

Are Women Better Investors Than Men?

There's been a battle of the sexes going on in the investing world for years, and I'm not about to turn it into a war by taking sides.

3 Hot Biotechs to Keep on Your Radar

The key to successfully investing in these biotechs is being able to sort the winners from the losers. Here are three picks that get a thumbs-up.

The Early Investor Bird Does Catch the Worm

When I look for investment opportunities, I am drawn to some of the world's most innovative companies and these 5 biotech stocks fit the bill for investment

3 Cyber Warfare Stocks to Buy Now

Critical needs often fuel growth industries, and from an investing standpoint, that’s what we’re seeing here in cyber security.

Lock In Gains in General Mills

This normally sleepy stock has enjoyed a huge run to start the year ... but don't get greedy. Take the gains and move on.

What Stocks Will Thrive Under a Second Obama Term?

Healthcare is one of the more apparent beneficiaries of a second Obama term. Two companies -- a generic drug-maker and medical device company -- stand out.

The Great Rotation from Bonds to Stocks

The tide is finally turning back to stocks for investors seeking yield. Here are some attractive names to consider that also offer appealing dividends.